Long-term safety and efficacy of apomorphine infusion in Parkinson's disease (PD) patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study

被引：0
|
作者：
Katzenschlager, R.
Poewe, W.
Rascol, O. [1 ]
Trenkwalder, C. [2 ]
Deuschl, G. [3 ]
Chaudhuri, R. [4 ]
Henriksen, T. [5 ]
Van Laar, T. [6 ]
Lockhart, D. [7 ]
Lees, A. [8 ]
机构：
[1] Univ Toulouse, Dept Neurosci & Clin Pharmacol, Toulouse, France
[2] Paracelsus Elena Klin, Kassel, Germany
[3] Univ Kiel, Dept Neurol, Kiel, Germany
[4] Kings Coll Hosp NHS Fdn Trust, Natl Parkinson Fdn Int Ctr Excellence, London, England
[5] Univ Hosp Bispebjerg, Movement Disorder Clin, Copenhagen, Denmark
[6] Univ Med Ctr Groningen, Neurol, Groningen, Netherlands
[7] Britannia Pharmaceut, Reading, Berks, England
[8] Natl Hosp Neurol & Neurosurg, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR2058
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
    Katzenschlager, Regina
    Poewe, Werner
    Rascol, Olivier
    Trenkwalder, Claudia
    Deuschl, Guenther
    Chaudhuri, K. Ray
    Henriksen, Tove
    van Laar, Teus
    Lockhart, Donna
    Staines, Harry
    Lees, Andrew
    PARKINSONISM & RELATED DISORDERS, 2021, 83 : 79 - 85
  • [2] Long-term safety and efficacy of apomorphine infusion in Parkinson's disease (PD) patients with persistent motor fluctuations: results of the 1-year open-label phase of the TOLEDO study
    Katzenschlager, R.
    Poewe, W.
    Rascol, O.
    Trenkwalder, C.
    Deuschl, G.
    Chaudhuri, K.
    Henriksen, T.
    van Laar, T.
    Lockhart, D.
    Lees, A.
    MOVEMENT DISORDERS, 2019, 34 : S52 - S53
  • [3] Safety and Efficacy of Continuous Apomorphine Infusion in Patients with Parkinson's disease: Results from a Phase 3, Open-label Study
    Isaacson, Stuart
    Espay, Alberto
    Pahwa, Rajesh
    Clinch, Thomas
    LeWitt, Peter
    NEUROLOGY, 2020, 94 (15)
  • [4] Continuous, Subcutaneous Apomorphine Infusion for Persistent Motor Fluctuations in Parkinson's Disease: Full results of the AP2-3000 open-label study
    Isaacson, Stuart
    Ceresoli-Borroni, Gianpiera
    Espay, Alberto
    Pahwa, Rajesh
    Agarwal, Pinky
    Shill, Holly
    Hui, Jennifer
    Dashtipour, Khashayar
    Lew, Mark
    Qin, Peibing
    Nasser, Azmi
    LeWitt, Peter
    NEUROLOGY, 2023, 100 (17)
  • [5] Long-term Efficacy of Inhaled Levodopa in Parkinson's Disease Subjects With Motor Fluctuations: a Phase 3 Open-Label Randomized Study
    Grosset, Donald
    Dhall, Rohit
    Gurevich, Tanya
    Kassubek, Jan
    Poewe, Werner H.
    Rascol, Olivier
    Rudzinska, Monika
    Cormier, Jennifer
    Sedkov, Alexander
    Oh, Charles
    NEUROLOGY, 2018, 90
  • [6] Long-term Efficacy of Inhaled Levodopa in Parkinson's Disease Subjects with Motor Fluctuations: A Phase 3 Open-label Randomized Study
    Grosset, Donald
    Dhall, Rohit
    Gurevich, Tanya
    Kassubek, Jan
    Poewe, Werner
    Rascol, Olivier
    Rudzinska, Monika
    Cormier, Jennifer
    Sedkov, Alexander
    Oh, Charles
    MOVEMENT DISORDERS, 2018, 33 : S88 - S89
  • [7] Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study
    Kassubek, Jan
    Factor, Stewart A.
    Balaguer, Ernest
    Schwarz, Johannes
    Chaudhuri, K. Ray
    Isaacson, Stuart H.
    Wu, Stacy
    Muhr, Carmen Denecke
    Kulisevsky, Jaime
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3554 - 3570
  • [8] INTERIM RESULTS FROM AN ONGOING, LONG-TERM, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF LEVODOPA/CARBIDOPA INTESTINAL GEL IN PATIENTS WITH PARKINSON'S DISEASE AND SEVERE MOTOR FLUCTUATIONS
    Odin, P.
    Chatamra, K.
    Espay, A. J.
    Standaert, D. G.
    Fernandez, H. H.
    Benesh, J.
    Robieson, W.
    Hass, S. L.
    Lenz, R. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 241 - 241
  • [9] Long-Term Pulmonary Safety of Inhaled Levodopa in Parkinson's Disease Subjects With Motor Fluctuations: a Phase 3 Open-Label Randomized Study
    Grosset, Donald
    Dhall, Rohit
    Gurevich, Tanya
    Kassubek, Jan
    Poewe, Werner H.
    Rascol, Olivier
    Rudzinska, Monika
    Cormier, Jennifer
    Sedkov, Alexander
    Oh, Charles
    NEUROLOGY, 2018, 90
  • [10] Long-term Pulmonary Safety of Inhaled Levodopa in Parkinson's Disease Subjects with Motor Fluctuations: A Phase 3 Open-label Randomized Study
    Grosset, Donald
    Dhall, Rohit
    Gurevich, Tanya
    Kassubek, Jan
    Poewe, Werner
    Rascol, Olivier
    Rudzinska, Monika
    Cormier, Jennifer
    Sedkov, Alexander
    Oh, Charles
    MOVEMENT DISORDERS, 2018, 33 : S89 - S89
12345